AI brief of an SEC Form 8-K · Regal Rexnord (RRX)

Regal Rexnord signs $1.5 billion revolver and $850 million term loan facilities

Neutral Impact 3 of 5 financing Written later

Regal Rexnord entered into a Third Amended and Restated Credit Agreement on November 21, 2025, replacing its 2022 credit agreement with an unsecured $850 million delayed draw term loan maturing in 2029 and an unsecured $1.5 billion revolving credit line maturing in 2030. The term loan will refinance the company's 6.050% Senior Notes due 2026, and the facilities will also cover general corporate purposes, so the deal changes the company's debt terms and maturities.

Key points

  • Delayed draw term loan of up to $850 million matures February 21, 2029; the proceeds will refinance the 6.050% Senior Notes due 2026.
  • Revolving credit line of up to $1.5 billion in dollars or other currencies matures November 21, 2030.
  • Maximum Funded Debt to EBITDA ratio of 4.00 to 1.00 for the first two fiscal quarters after closing, then 3.75 to 1.00; minimum Interest Coverage Ratio of 3.00 to 1.00.
  • Facilities replace the Second Amended and Restated Credit Agreement dated March 28, 2022, with JPMorgan Chase Bank, N.A. as administrative agent.

The filing

CompanyRegal Rexnord (RRX)
Form8-K, current report
Filed with the SECNov 25, 2025, 4:18 PM ET
Accession number0000082811-25-000220

Items reported: 1.01 Material Definitive Agreement2.03 New Direct Financial Obligation

Read the filing on SEC.gov ↗

Written by AI (Anthropic Claude, claude-haiku-5-5) on Nov 8, 2026, 12:56 AM ET, from the text of the filing and its press-release exhibits only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on November 25, 2025.

Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.